<DOC>
	<DOCNO>NCT00790387</DOCNO>
	<brief_summary>Patients undergo coronary angioplasty frequently treat new drug stop blood platelet work improve success procedure . Individual patient may vary dose drug require . New platelet test develop perform near patient possibly immediately tell doctor degree platelet inhibition achieve dose adjust accordingly . This study aim investigate platelet test indicate new anticoagulant effective inhibit platelet function traditional anticoagulant . The study demonstrate newer drug improve blood flow heart muscle thereby provide good long term outcomes patient undergo percutaneous intervention .</brief_summary>
	<brief_title>Tirofiban Enoxaparin High Risk Coronary Intervention</brief_title>
	<detailed_description>Objectives : The study assess benefit high bolus dose tirofiban enoxaparin compare unfractionated heparin . Introduction : The benefit use glycoprotein IIb/IIa inhibitor low molecular weight heparin high risk patient undergo percutaneous intervention ( PCI ) traditional unfractionated heparin ( UFH ) debate . Methods ; The study prospective single center open-label trial patient high-risk acute coronary syndrome treat PCI randomise anticoagulation UFH enoxaparin 'high dose ' ( 25 mcg/kg bolus ) tirofiban This study measure panel platelet activation marker , inflammatory biomarkers thrombus generation two group .</detailed_description>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<mesh_term>Tirofiban</mesh_term>
	<criteria>Patients recruit undergoing PCI plan placement intracoronary stent Including patient unstable angina pectoris , acute coronary syndrome NSTEMI Experienced ischaemic pain rest Lasting 10 minute occur within 7 day enrollment As well one following : ECG change : New presumably new STsegment depression great equal 0.1 mV ( 1 mm ) , transient ( &lt; 30 minute ) STsegment elevation great equal 0.1 mV ( 1 mm ) least 2 contiguous lead Abnormal cardiac enzyme within 24 hour enrollment , define elevated Troponin I define elevated Troponin I ( normal reference Highrisk angiographic feature include intraluminal filling defect , angiographically visible thrombus eccentric lesion , type , location proximal major vessel thrombolysis myocardial infarction ( TIMI ) flow II less Increased bleed risk : ischaemic stroke within last year previous haemorrhagic stroke , tumour intracranial aneurysm ; Recent ( &lt; 1 month ) trauma major surgery ( include bypass surgery ) ; Active bleeding Unexplained clinically significant bleeding , thrombocytopenia ( platelet count &lt; 100 x 109/L ) history thrombocytopenia GP IIb/IIIa , heparin enoxaparin therapy Angina secondary cause severe uncontrolled hypertension ( systolic blood pressure &gt; 180 mm Hg despite treatment ) Valvular disease , congenital heart disease , hypertrophic cardiomyopathy , Thrombolytic therapy within precede 24 hour Receiving antiIIb/IIIa therapy Creatinine clearance &lt; 30 mL/min</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>enoxaparin</keyword>
	<keyword>tirofiban</keyword>
	<keyword>percutaneous intervention</keyword>
	<keyword>platelet inhibition</keyword>
	<keyword>CD40L</keyword>
	<keyword>Mac-1</keyword>
	<keyword>prothrombin fragment 1+2 .</keyword>
</DOC>